The Eisenmenger syndrome in adults
- PMID: 9556469
- DOI: 10.7326/0003-4819-128-9-199805010-00008
The Eisenmenger syndrome in adults
Abstract
For this article, the literature on the pathophysiology, clinical features, natural history, prognosis, and management of the Eisenmenger syndrome in adults was reviewed. English-language articles from 1966 to the present were identified through a search of the MEDLINE database by using the terms Eisenmenger, congenital heart disease, and pulmonary hypertension. Selected cross-referenced articles were also included. Articles on the pathophysiology, clinical presentation, evaluation, natural history, complications, and treatment of the Eisenmenger syndrome in adults were selected, and descriptive and analytical data relevant to the practicing physician were manually extracted. The Eisenmenger syndrome is characterized by elevated pulmonary vascular resistance and right-to-left shunting of blood through a systemic-to-pulmonary circulation connection. Most patients with the syndrome survive for 20 to 30 years. The hemostatic changes associated with the syndrome may lead to thromboembolic events, cerebrovascular complications, or the hyperviscosity syndrome. Erythrocytosis is present in most patients, but excessive phlebotomy may cause microcytosis and exacerbate the symptoms of hyperviscosity. Other complications associated with the Eisenmenger syndrome include hemoptysis, gout, cholelithiasis, hypertrophic osteoarthropathy, and decreased renal function. Pregnancy or noncardiac surgery is associated with a high mortality rate in patients with the Eisenmenger syndrome. Because most pediatric patients with the Eisenmenger syndrome survive to adulthood, primary care physicians should have a thorough understanding of the syndrome; its associated complications; and medical and surgical management, especially with regard to the appropriate timing of phlebotomy and lung or heart-lung transplantation. In addition, patients with the syndrome should undergo routine follow-up at a tertiary care center that has physicians and nurses with special expertise in congenital heart disease. In patients with the Eisenmenger syndrome who are pregnant or require noncardiac surgery, a multidisciplinary approach should be used to reduce the excessive mortality associated with these conditions.
Similar articles
-
[Eisenmenger syndrome].Ugeskr Laeger. 2009 Apr 6;171(15):1270-5. Ugeskr Laeger. 2009. PMID: 19416617 Review. Danish.
-
Eisenmenger Syndrome in Pregnancy.Braz J Cardiovasc Surg. 2016 Jul-Sep;31(4):325-329. doi: 10.5935/1678-9741.20160062. Braz J Cardiovasc Surg. 2016. PMID: 27849306 Free PMC article. Review.
-
Preventing disease progression in Eisenmenger syndrome.Expert Rev Cardiovasc Ther. 2021 Jun;19(6):501-518. doi: 10.1080/14779072.2021.1917995. Epub 2021 May 6. Expert Rev Cardiovasc Ther. 2021. PMID: 33853494 Review.
-
Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome.J Heart Lung Transplant. 1996 Jan;15(1 Pt 1):100-5. J Heart Lung Transplant. 1996. PMID: 8820089
-
[Eisenmenger syndrome. Conventional treatments and general management].Presse Med. 2009 Dec;38 Suppl 1:1S14-7. doi: 10.1016/S0755-4982(09)73419-0. Presse Med. 2009. PMID: 20141996 French.
Cited by
-
Pregnancy in patients with heart disease: experience with 1,000 cases.Clin Cardiol. 2003 Mar;26(3):135-42. doi: 10.1002/clc.4960260308. Clin Cardiol. 2003. PMID: 12685620 Free PMC article.
-
Central retinal artery occlusion with cilioretinal sparing in a patient with Eisenmenger syndrome.BMJ Case Rep. 2022 Feb 28;15(2):e246293. doi: 10.1136/bcr-2021-246293. BMJ Case Rep. 2022. PMID: 35228223 Free PMC article.
-
Long-term oral bosentan treatment in patients with pulmonary arterial hypertension related to congenital heart disease: a 2-year study.Heart. 2007 Mar;93(3):350-4. doi: 10.1136/hrt.2006.100388. Epub 2006 Sep 15. Heart. 2007. PMID: 16980516 Free PMC article. Clinical Trial.
-
Effect of bosentan therapy on ventricular and atrial function in adults with Eisenmenger syndrome. A prospective, multicenter study using conventional and Speckle tracking echocardiography.Clin Res Cardiol. 2014 Sep;103(9):701-10. doi: 10.1007/s00392-014-0703-5. Epub 2014 Mar 30. Clin Res Cardiol. 2014. PMID: 24682249
-
Asymmetric Dimethyl-L-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease.Pediatr Cardiol. 2015 Jun;36(5):1062-9. doi: 10.1007/s00246-015-1127-3. Epub 2015 Mar 4. Pediatr Cardiol. 2015. PMID: 25737007
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources